← NDC auxiliary source history
Current NDC auxiliary source rows
Every current FDA unfinished, excluded, package, product, and compounder source row. Empty or malformed identifiers and report-scoped rows remain addressable by their exact source record and row.
Counts come from the five current base tables. The atomic loader verifies that every base source row has exactly one status projection before publication; directory pages use that verified projection and retain exact base-row detail links.
| Exact source record | Source row | Dataset | Record source | Scope | Status | Status meaning | Product NDC | Package NDC | Product / substance | Application | Reporting period | Normalization | Notes | Source date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
outsourcing:2020-2:1608 | 1608 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Tacrolimus | 2020-2 | source_no_ndc | 1 | 2026-10-22 | |||
outsourcing:2021-1:1608 | 1608 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-0324 | 26436-0324-1 | Progesterone | 2021-1 | valid | 0 | 2026-10-22 | |
outsourcing:2021-2:1608 | 1608 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ropivacaine Hydrochloride | 2021-2 | source_no_ndc | 1 | 2026-10-22 | |||
outsourcing:2022-1:1608 | 1608 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Vancomycin | 2022-1 | source_no_ndc | 1 | 2026-10-22 | |||
outsourcing:2022-2:1608 | 1608 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-6286 | 71266-6286-3 | Tetracaine Hydrochloride; Lidocaine Hydrochloride; Epinephrine | 2022-2 | valid | 0 | 2026-10-22 | |
outsourcing:2023-1:1608 | 1608 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69761-872 | 69761-872-01 | Testosterone | 2023-1 | valid | 0 | 2026-10-22 | |
outsourcing:2023-2:1608 | 1608 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-0122 | 70168-0122-1 | Testosterone | 2023-2 | valid | 0 | 2026-10-22 | |
outsourcing:2024-1:1608 | 1608 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 68985-324 | 68985-324-93 | Vancomycin Hydrochloride | 2024-1 | valid | 0 | 2026-10-22 | |
outsourcing:2024-2:1608 | 1608 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Vancomycin Hydrochloride | 2024-2 | source_no_ndc | 1 | 2026-10-22 | |||
outsourcing:2025-1:1608 | 1608 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-3611 | 72934-3611-2 | Urea; Ciclopirox Olamine; Itraconazole | 2025-1 | valid | 0 | 2026-10-22 | |
compounder:1609 | 1609 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-4350 | 72934-4350-8 | Oxopod Solution | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1609 | 1609 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-22 | |||
outsourcing:2019-2:1609 | 1609 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ranibizumab | 2019-2 | source_no_ndc | 1 | 2026-10-22 | |||
outsourcing:2020-1:1609 | 1609 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-079 | 71449-079-59 | Ropivacaine Hydrochloride | 2020-1 | valid | 0 | 2026-10-22 | |
outsourcing:2020-2:1609 | 1609 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 79926-006 | 79926-006-01 | Tacrolimus | 2020-2 | valid | 0 | 2026-10-22 | |
outsourcing:2021-1:1609 | 1609 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5363 | 26436-5363-1 | Progesterone | 2021-1 | valid | 0 | 2026-10-22 | |
outsourcing:2021-2:1609 | 1609 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ropivacaine Hydrochloride; Clonidine Hydrochloride; Ketorolac Tromethamine; Epinephrine | 2021-2 | source_no_ndc | 1 | 2026-10-22 | |||
outsourcing:2022-1:1609 | 1609 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Vancomycin | 2022-1 | source_no_ndc | 1 | 2026-10-22 | |||
outsourcing:2022-2:1609 | 1609 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Tetracaine Hydrochloride; Racepinephrine Hydrochloride; Lidocaine Hydrochloride | 2022-2 | source_no_ndc | 1 | 2026-10-22 | |||
outsourcing:2023-1:1609 | 1609 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-002 | 70713-002-01 | Testosterone | 2023-1 | valid | 0 | 2026-10-22 | |
outsourcing:2023-2:1609 | 1609 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-0030 | 70168-0030-1 | Testosterone | 2023-2 | valid | 0 | 2026-10-22 | |
outsourcing:2024-1:1609 | 1609 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-7060 | 71285-7060-1 | Vancomycin Hydrochloride | 2024-1 | valid | 0 | 2026-10-22 | |
outsourcing:2024-2:1609 | 1609 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5075 | 71266-5075-1 | Vancomycin Hydrochloride | 2024-2 | valid | 0 | 2026-10-22 | |
outsourcing:2025-1:1609 | 1609 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1544 | 72934-1544-6 | Urea; Lactic Acid | 2025-1 | valid | 0 | 2026-10-22 | |
compounder:1610 | 1610 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 63037-164 | 63037-164-25 | Lidocaine HCl | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1610 | 1610 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-720 | 70004-720-05 | Lidocaine Hydrochloride | 2019-1 | valid | 0 | 2026-10-22 | |
outsourcing:2019-2:1610 | 1610 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Remifentanil Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-22 | |||
outsourcing:2020-1:1610 | 1610 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-079 | 71449-079-57 | Ropivacaine Hydrochloride | 2020-1 | valid | 0 | 2026-10-22 | |
outsourcing:2020-2:1610 | 1610 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 79926-007 | 79926-007-01 | Tacrolimus | 2020-2 | valid | 0 | 2026-10-22 | |
outsourcing:2021-1:1610 | 1610 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 62295-8235 | 62295-8235-1 | Promethazine | 2021-1 | valid | 0 | 2026-10-22 | |
outsourcing:2021-2:1610 | 1610 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-211 | 73702-211-02 | Ropivacaine Hydrochloride; Fentanyl | 2021-2 | valid | 0 | 2026-10-22 | |
outsourcing:2022-1:1610 | 1610 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Vancomycin Hydrochloride | 2022-1 | source_no_ndc | 1 | 2026-10-22 | |||
outsourcing:2022-2:1610 | 1610 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Tetracaine Hydrochloride; Racepinephrine Hydrochloride; Lidocaine Hydrochloride | 2022-2 | source_no_ndc | 1 | 2026-10-22 | |||
outsourcing:2023-1:1610 | 1610 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-033 | 70713-033-01 | Testosterone | 2023-1 | valid | 0 | 2026-10-22 | |
outsourcing:2023-2:1610 | 1610 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-0020 | 70168-0020-1 | Testosterone | 2023-2 | valid | 0 | 2026-10-22 | |
outsourcing:2024-1:1610 | 1610 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Vancomycin Hydrochloride | 2024-1 | source_no_ndc | 1 | 2026-10-22 | |||
outsourcing:2024-2:1610 | 1610 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5073 | 71266-5073-1 | Vancomycin Hydrochloride | 2024-2 | valid | 0 | 2026-10-22 | |
outsourcing:2025-1:1610 | 1610 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0427 | 71285-0427-1 | Valine; Calcium Gluconate Monohydrate; Heparin Sodium; Glutamic Acid; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan | 2025-1 | valid | 0 | 2026-10-22 | |
compounder:1611 | 1611 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-250 | 70092-250-75 | Fent PF10 mcg/ml 100 ml NS CADD- C FSFF | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1611 | 1611 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-720 | 70004-720-12 | Lidocaine Hydrochloride | 2019-1 | valid | 0 | 2026-10-22 | |
outsourcing:2019-2:1611 | 1611 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Riboflavin; Ascorbic Acid; Magnesium Chloride; Dexpanthenol; Niacinamide; Hydroxocobalamin; Calcium Gluconate; Pyridoxine; Thiamine Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-22 | |||
outsourcing:2020-1:1611 | 1611 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-079 | 71449-079-34 | Ropivacaine Hydrochloride | 2020-1 | valid | 0 | 2026-10-22 | |
outsourcing:2020-2:1611 | 1611 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 79926-008 | 79926-008-01 | Tacrolimus | 2020-2 | valid | 0 | 2026-10-22 | |
outsourcing:2021-1:1611 | 1611 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1341 | 5446-1341-01 | Promethazine Hydrochloride | 2021-1 | valid | 0 | 2026-10-22 | |
outsourcing:2021-2:1611 | 1611 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ropivacaine Hydrochloride; Fentanyl Citrate | 2021-2 | source_no_ndc | 1 | 2026-10-22 | |||
outsourcing:2022-1:1611 | 1611 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Vancomycin Hydrochloride | 2022-1 | source_no_ndc | 1 | 2026-10-22 | |||
outsourcing:2022-2:1611 | 1611 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Tetracaine Hydrochloride; Racepinephrine Hydrochloride; Lidocaine Hydrochloride | 2022-2 | source_no_ndc | 1 | 2026-10-22 | |||
outsourcing:2023-1:1611 | 1611 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-055 | 70713-055-01 | Testosterone | 2023-1 | valid | 0 | 2026-10-22 | |
outsourcing:2023-2:1611 | 1611 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-0031 | 70168-0031-1 | Testosterone | 2023-2 | valid | 0 | 2026-10-22 | |
outsourcing:2024-1:1611 | 1611 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-019 | 71506-019-59 | Vancomycin Hydrochloride | 2024-1 | valid | 0 | 2026-10-22 | |
outsourcing:2024-2:1611 | 1611 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Vancomycin Hydrochloride | 2024-2 | source_no_ndc | 1 | 2026-10-22 | |||
outsourcing:2025-1:1611 | 1611 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6071 | 72196-6071-1 | Vancomycin Hydrochloride | 2025-1 | valid | 0 | 2026-10-22 | |
compounder:1612 | 1612 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-045 | 70092-045-05 | Phenylephrine 50 mg add to 250ml NS bag | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1612 | 1612 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-723 | 70004-723-09 | Lidocaine Hydrochloride | 2019-1 | valid | 0 | 2026-10-22 | |
outsourcing:2019-2:1612 | 1612 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-850 | 70004-850-12 | Rocuronium Bromide | 2019-2 | valid | 0 | 2026-10-22 | |
outsourcing:2020-1:1612 | 1612 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-070 | 71449-070-31 | Ropivacaine Hydrochloride | 2020-1 | valid | 0 | 2026-10-22 | |
outsourcing:2020-2:1612 | 1612 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 79926-009 | 79926-009-01 | Tacrolimus | 2020-2 | valid | 0 | 2026-10-22 | |
outsourcing:2021-1:1612 | 1612 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 61141-4536 | 61141-4536-4 | Proparacaine Hydrochloride | 2021-1 | valid | 0 | 2026-10-22 | |
outsourcing:2021-2:1612 | 1612 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ropivacaine Hydrochloride; Fentanyl Citrate | 2021-2 | source_no_ndc | 1 | 2026-10-22 | |||
outsourcing:2022-1:1612 | 1612 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Vancomycin Hydrochloride | 2022-1 | source_no_ndc | 1 | 2026-10-22 | |||
outsourcing:2022-2:1612 | 1612 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-101 | 70713-101-01 | Tetracaine; Benzocaine; Lidocaine | 2022-2 | valid | 0 | 2026-10-22 | |
outsourcing:2023-1:1612 | 1612 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-006 | 70713-006-01 | Testosterone | 2023-1 | valid | 0 | 2026-10-22 | |
outsourcing:2023-2:1612 | 1612 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-0021 | 70168-0021-1 | Testosterone | 2023-2 | valid | 0 | 2026-10-22 | |
outsourcing:2024-1:1612 | 1612 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-017 | 71506-017-59 | Vancomycin Hydrochloride | 2024-1 | valid | 0 | 2026-10-22 | |
outsourcing:2024-2:1612 | 1612 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71170-264 | 71170-264-25 | Vancomycin Hydrochloride | 2024-2 | valid | 0 | 2026-10-22 | |
outsourcing:2025-1:1612 | 1612 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6074 | 72196-6074-1 | Vancomycin Hydrochloride | 2025-1 | valid | 0 | 2026-10-22 | |
compounder:1613 | 1613 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 81483-0006 | 81483-0006-0 | Ketamine | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1613 | 1613 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-720 | 70004-720-09 | Lidocaine Hydrochloride | 2019-1 | valid | 0 | 2026-10-22 | |
outsourcing:2019-2:1613 | 1613 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-850 | 70004-850-28 | Rocuronium Bromide | 2019-2 | valid | 0 | 2026-10-22 | |
outsourcing:2020-1:1613 | 1613 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ropivacaine Hydrochloride; Fentanyl Citrate | 2020-1 | source_no_ndc | 1 | 2026-10-22 | |||
outsourcing:2020-2:1613 | 1613 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 79926-010 | 79926-010-01 | Tacrolimus | 2020-2 | valid | 0 | 2026-10-22 | |
outsourcing:2021-1:1613 | 1613 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Pyridoxine | 2021-1 | source_no_ndc | 1 | 2026-10-22 | |||
outsourcing:2021-2:1613 | 1613 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ropivacaine Hydrochloride; Fentanyl Citrate | 2021-2 | source_no_ndc | 1 | 2026-10-22 | |||
outsourcing:2022-1:1613 | 1613 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Vancomycin Hydrochloride | 2022-1 | source_no_ndc | 1 | 2026-10-22 | |||
outsourcing:2022-2:1613 | 1613 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-1003 | 73271-1003-1 | Tetracaine; Epinephrine Bitartrate; Lidocaine | 2022-2 | valid | 0 | 2026-10-22 | |
outsourcing:2023-1:1613 | 1613 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69761-202 | 69761-202-01 | Testosterone | 2023-1 | valid | 0 | 2026-10-22 | |
outsourcing:2023-2:1613 | 1613 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69761-102 | 69761-102-01 | Testosterone | 2023-2 | valid | 0 | 2026-10-22 | |
outsourcing:2024-1:1613 | 1613 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-016 | 71506-016-59 | Vancomycin Hydrochloride | 2024-1 | valid | 0 | 2026-10-22 | |
outsourcing:2024-2:1613 | 1613 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71170-194 | 71170-194-50 | Vancomycin Hydrochloride | 2024-2 | valid | 0 | 2026-10-22 | |
outsourcing:2025-1:1613 | 1613 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6075 | 72196-6075-1 | Vancomycin Hydrochloride | 2025-1 | valid | 0 | 2026-10-22 | |
compounder:1614 | 1614 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5027 | 26436-5027-2 | Alpha Lipoic acid | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1614 | 1614 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-22 | |||
outsourcing:2019-2:1614 | 1614 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-850 | 70004-850-09 | Rocuronium Bromide | 2019-2 | valid | 0 | 2026-10-22 | |
outsourcing:2020-1:1614 | 1614 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ropivacaine Hydrochloride; Fentanyl Citrate | 2020-1 | source_no_ndc | 1 | 2026-10-22 | |||
outsourcing:2020-2:1614 | 1614 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Tacrolimus | 2020-2 | source_no_ndc | 1 | 2026-10-22 | |||
outsourcing:2021-1:1614 | 1614 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Pyridoxine | 2021-1 | source_no_ndc | 1 | 2026-10-22 | |||
outsourcing:2021-2:1614 | 1614 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ropivacaine Hydrochloride; Fentanyl Citrate | 2021-2 | source_no_ndc | 1 | 2026-10-22 | |||
outsourcing:2022-1:1614 | 1614 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Vancomycin Hydrochloride | 2022-1 | source_no_ndc | 1 | 2026-10-22 | |||
outsourcing:2022-2:1614 | 1614 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Tetracaine; Lidocaine; Benzocaine | 2022-2 | source_no_ndc | 1 | 2026-10-22 | |||
outsourcing:2023-1:1614 | 1614 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69761-252 | 69761-252-01 | Testosterone | 2023-1 | valid | 0 | 2026-10-22 | |
outsourcing:2023-2:1614 | 1614 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69761-502 | 69761-502-01 | Testosterone | 2023-2 | valid | 0 | 2026-10-22 | |
outsourcing:2024-1:1614 | 1614 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71170-244 | 71170-244-25 | Vancomycin Hydrochloride | 2024-1 | valid | 0 | 2026-10-22 | |
outsourcing:2024-2:1614 | 1614 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71170-184 | 71170-184-25 | Vancomycin Hydrochloride | 2024-2 | valid | 0 | 2026-10-22 | |
outsourcing:2025-1:1614 | 1614 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83556-0510 | 83556-0510-2 | Vancomycin Hydrochloride | 2025-1 | valid | 0 | 2026-10-22 | |
compounder:1615 | 1615 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-2050 | 70168-2050-1 | E2 18mg | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1615 | 1615 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-22 | |||
outsourcing:2019-2:1615 | 1615 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Rocuronium Bromide | 2019-2 | source_no_ndc | 1 | 2026-10-22 | |||
outsourcing:2020-1:1615 | 1615 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ropivacaine Hydrochloride; Fentanyl Citrate | 2020-1 | source_no_ndc | 1 | 2026-10-22 | |||
outsourcing:2020-2:1615 | 1615 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72833-805 | 72833-805-01 | Tadalafil | 2020-2 | valid | 0 | 2026-10-22 | |
outsourcing:2021-1:1615 | 1615 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2424 | 72627-2424-1 | Pyridoxine Hydrochloride | 2021-1 | valid | 0 | 2026-10-22 | |
outsourcing:2021-2:1615 | 1615 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ropivacaine Hydrochloride; Fentanyl Citrate | 2021-2 | source_no_ndc | 1 | 2026-10-22 | |||
outsourcing:2022-1:1615 | 1615 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Vancomycin Hydrochloride | 2022-1 | source_no_ndc | 1 | 2026-10-22 | |||
outsourcing:2022-2:1615 | 1615 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Tetracaine; Lidocaine; Benzocaine | 2022-2 | source_no_ndc | 1 | 2026-10-22 | |||
outsourcing:2023-1:1615 | 1615 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69761-102 | 69761-102-01 | Testosterone | 2023-1 | valid | 0 | 2026-10-22 | |
outsourcing:2023-2:1615 | 1615 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69761-872 | 69761-872-01 | Testosterone | 2023-2 | valid | 0 | 2026-10-22 | |
outsourcing:2024-1:1615 | 1615 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71170-254 | 71170-254-25 | Vancomycin Hydrochloride | 2024-1 | valid | 0 | 2026-10-22 | |
outsourcing:2024-2:1615 | 1615 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71170-185 | 71170-185-50 | Vancomycin Hydrochloride | 2024-2 | valid | 0 | 2026-10-22 | |
outsourcing:2025-1:1615 | 1615 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6071 | 71285-6071-1 | Vancomycin Hydrochloride | 2025-1 | valid | 0 | 2026-10-22 | |
compounder:1616 | 1616 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-3030 | 70168-3030-1 | Progesterone 75mg | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1616 | 1616 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9060 | 71266-9060-1 | Lidocaine Hydrochloride | 2019-1 | valid | 0 | 2026-10-22 | |
outsourcing:2019-2:1616 | 1616 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9005 | 71266-9005-5 | Rocuronium Bromide | 2019-2 | valid | 0 | 2026-10-22 | |
outsourcing:2020-1:1616 | 1616 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ropivacaine Hydrochloride; Fentanyl Citrate | 2020-1 | source_no_ndc | 1 | 2026-10-22 | |||
outsourcing:2020-2:1616 | 1616 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Tadalafil | 2020-2 | source_no_ndc | 1 | 2026-10-22 | |||
outsourcing:2021-1:1616 | 1616 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Pyridoxine Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-22 | |||
outsourcing:2021-2:1616 | 1616 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ropivacaine Hydrochloride; Fentanyl Citrate | 2021-2 | source_no_ndc | 1 | 2026-10-22 | |||
outsourcing:2022-1:1616 | 1616 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 68985-304 | 68985-304-92 | Vancomycin Hydrochloride | 2022-1 | valid | 0 | 2026-10-22 | |
outsourcing:2022-2:1616 | 1616 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Tetracaine; Lidocaine; Benzocaine | 2022-2 | source_no_ndc | 1 | 2026-10-22 | |||
outsourcing:2023-1:1616 | 1616 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69761-502 | 69761-502-01 | Testosterone | 2023-1 | valid | 0 | 2026-10-22 | |
outsourcing:2023-2:1616 | 1616 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-0121 | 70168-0121-1 | Testosterone | 2023-2 | valid | 0 | 2026-10-22 | |
outsourcing:2024-1:1616 | 1616 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71170-264 | 71170-264-25 | Vancomycin Hydrochloride | 2024-1 | valid | 0 | 2026-10-22 | |
outsourcing:2024-2:1616 | 1616 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Vancomycin Hydrochloride | 2024-2 | source_no_ndc | 1 | 2026-10-22 | |||
outsourcing:2025-1:1616 | 1616 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6073 | 71285-6073-1 | Vancomycin Hydrochloride | 2025-1 | valid | 0 | 2026-10-22 | |
compounder:1617 | 1617 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-207 | 70092-207-37 | Fent2mcg/ml-Ropiv0.1%PF 200ml NS- 250IVB | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1617 | 1617 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9050 | 71266-9050-2 | Lidocaine Hydrochloride | 2019-1 | valid | 0 | 2026-10-22 | |
outsourcing:2019-2:1617 | 1617 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-2002 | 71266-2002-1 | Rocuronium Bromide | 2019-2 | valid | 0 | 2026-10-22 | |
outsourcing:2020-1:1617 | 1617 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ropivacaine Hydrochloride; Fentanyl Citrate | 2020-1 | source_no_ndc | 1 | 2026-10-22 | |||
outsourcing:2020-2:1617 | 1617 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Tadalafil | 2020-2 | source_no_ndc | 1 | 2026-10-22 | |||
outsourcing:2021-1:1617 | 1617 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72833-626 | 72833-626-30 | Pyridoxine Hydrochloride | 2021-1 | valid | 0 | 2026-10-22 | |
outsourcing:2021-2:1617 | 1617 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ropivacaine Hydrochloride; Fentanyl Citrate | 2021-2 | source_no_ndc | 1 | 2026-10-22 | |||
outsourcing:2022-1:1617 | 1617 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 68985-324 | 68985-324-93 | Vancomycin Hydrochloride | 2022-1 | valid | 0 | 2026-10-22 | |
outsourcing:2022-2:1617 | 1617 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Tetracaine; Lidocaine; Benzocaine | 2022-2 | source_no_ndc | 1 | 2026-10-22 | |||
outsourcing:2023-1:1617 | 1617 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5146 | 26436-5146-5 | Testosterone Cypionate | 2023-1 | valid | 0 | 2026-10-22 | |
outsourcing:2023-2:1617 | 1617 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-0011 | 70168-0011-1 | Testosterone | 2023-2 | valid | 0 | 2026-10-22 | |
outsourcing:2024-1:1617 | 1617 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71170-194 | 71170-194-50 | Vancomycin Hydrochloride | 2024-1 | valid | 0 | 2026-10-22 | |
outsourcing:2024-2:1617 | 1617 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Vancomycin Hydrochloride | 2024-2 | source_no_ndc | 1 | 2026-10-22 | |||
outsourcing:2025-1:1617 | 1617 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6074 | 71285-6074-1 | Vancomycin Hydrochloride | 2025-1 | valid | 0 | 2026-10-22 | |
compounder:1618 | 1618 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1047 | 73013-1047-1 | Fentanyl Citrate- Ropivacaine HCl | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1618 | 1618 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9050 | 71266-9050-3 | Lidocaine Hydrochloride | 2019-1 | valid | 0 | 2026-10-22 | |
outsourcing:2019-2:1618 | 1618 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Rocuronium Bromide | 2019-2 | source_no_ndc | 1 | 2026-10-22 | |||
outsourcing:2020-1:1618 | 1618 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-519 | 69374-519-50 | Ropivacaine Hydrochloride; Ketamine; Ketorolac Tromethamine | 2020-1 | valid | 0 | 2026-10-22 | |
outsourcing:2020-2:1618 | 1618 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-0059 | 26436-0059-1 | Tadalafil | 2020-2 | valid | 0 | 2026-10-22 | |
outsourcing:2021-1:1618 | 1618 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70731-956 | 70731-956-30 | Pyridoxine Hydrochloride | 2021-1 | valid | 0 | 2026-10-22 | |
outsourcing:2021-2:1618 | 1618 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ropivacaine Hydrochloride; Fentanyl Citrate | 2021-2 | source_no_ndc | 1 | 2026-10-22 | |||
outsourcing:2022-1:1618 | 1618 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6074 | 71285-6074-1 | Vancomycin Hydrochloride | 2022-1 | valid | 0 | 2026-10-22 | |
outsourcing:2022-2:1618 | 1618 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Tetracaine; Lidocaine; Benzocaine | 2022-2 | source_no_ndc | 1 | 2026-10-22 | |||
outsourcing:2023-1:1618 | 1618 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2100 | 72627-2100-1 | Testosterone Cypionate | 2023-1 | valid | 0 | 2026-10-22 | |
outsourcing:2023-2:1618 | 1618 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-8200 | 72682-8200-1 | Testosterone | 2023-2 | valid | 0 | 2026-10-22 | |
outsourcing:2024-1:1618 | 1618 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71170-184 | 71170-184-25 | Vancomycin Hydrochloride | 2024-1 | valid | 0 | 2026-10-22 | |
outsourcing:2024-2:1618 | 1618 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6074 | 72196-6074-1 | Vancomycin Hydrochloride | 2024-2 | valid | 0 | 2026-10-22 | |
outsourcing:2025-1:1618 | 1618 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6076 | 72196-6076-1 | Vancomycin Hydrochloride | 2025-1 | valid | 0 | 2026-10-22 | |
compounder:1619 | 1619 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0420 | 72196-0420-1 | Trophamine 3%/Dextrose 10% With Calcium Gluconate 3.75mEq and Heparin 125 units 250ml in 250ml bag | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1619 | 1619 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1147 | 5446-1147-01 | Lidocaine Hydrochloride | 2019-1 | valid | 0 | 2026-10-22 | |
outsourcing:2019-2:1619 | 1619 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Rocuronium Bromide | 2019-2 | source_no_ndc | 1 | 2026-10-22 | |||
outsourcing:2020-1:1619 | 1619 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-515 | 69374-515-50 | Ropivacaine Hydrochloride; Ketorolac Tromethamine; Clonidine Hydrochloride | 2020-1 | valid | 0 | 2026-10-22 | |
outsourcing:2020-2:1619 | 1619 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-061 | 70713-061-03 | Taurine | 2020-2 | valid | 0 | 2026-10-22 | |
outsourcing:2021-1:1619 | 1619 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Pyridoxine Hydrochloride; Magnesium Chloride; Dexpanthenol; Calcium Gluconate; Thiamine Hydrochloride; Niacinamide; Cyanocobalamin; Riboflavin | 2021-1 | source_no_ndc | 1 | 2026-10-22 | |||
outsourcing:2021-2:1619 | 1619 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ropivacaine Hydrochloride; Fentanyl Citrate | 2021-2 | source_no_ndc | 1 | 2026-10-22 | |||
outsourcing:2022-1:1619 | 1619 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6075 | 71285-6075-1 | Vancomycin Hydrochloride | 2022-1 | valid | 0 | 2026-10-22 | |
outsourcing:2022-2:1619 | 1619 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Tetracaine; Lidocaine; Benzocaine | 2022-2 | source_no_ndc | 1 | 2026-10-22 | |||
outsourcing:2023-1:1619 | 1619 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-1225 | 73271-1225-1 | Testosterone Cypionate | 2023-1 | valid | 0 | 2026-10-22 | |
outsourcing:2023-2:1619 | 1619 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-8037 | 72682-8037-1 | Testosterone | 2023-2 | valid | 0 | 2026-10-22 | |
outsourcing:2024-1:1619 | 1619 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71170-185 | 71170-185-50 | Vancomycin Hydrochloride | 2024-1 | valid | 0 | 2026-10-22 | |
outsourcing:2024-2:1619 | 1619 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6075 | 72196-6075-1 | Vancomycin Hydrochloride | 2024-2 | valid | 0 | 2026-10-22 | |
outsourcing:2025-1:1619 | 1619 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Vancomycin Hydrochloride | 2025-1 | source_no_ndc | 1 | 2026-10-22 | |||
compounder:1620 | 1620 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-0180 | 73271-0180-1 | TESTOSTERONE 18 PEL | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1620 | 1620 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-728 | 70004-728-12 | Lidocaine Hydrochloride | 2019-1 | valid | 0 | 2026-10-22 | |
outsourcing:2019-2:1620 | 1620 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Rocuronium Bromide | 2019-2 | source_no_ndc | 1 | 2026-10-22 | |||
outsourcing:2020-1:1620 | 1620 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-0970 | 5446-0970-03 | Salicylic Acid; Podophyllum Resin; Cantharidin | 2020-1 | valid | 0 | 2026-10-22 | |
outsourcing:2020-2:1620 | 1620 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72833-635 | 72833-635-30 | Taurine | 2020-2 | valid | 0 | 2026-10-22 | |
outsourcing:2021-1:1620 | 1620 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69389-155 | 69389-155-23 | Pyridoxine Hydrochloride; Riboflavin 5'-Phosphate Sodium; Chromic Chloride; Thiamine Hydrochloride; Niacinamide Hydrochloride | 2021-1 | valid | 0 | 2026-10-22 | |
outsourcing:2021-2:1620 | 1620 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71170-950 | 71170-950-25 | Ropivacaine Hydrochloride; Fentanyl Citrate | 2021-2 | valid | 0 | 2026-10-22 | |
outsourcing:2022-1:1620 | 1620 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6076 | 71285-6076-1 | Vancomycin Hydrochloride | 2022-1 | valid | 0 | 2026-10-22 | |
outsourcing:2022-2:1620 | 1620 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Tetracaine; Lidocaine; Benzocaine | 2022-2 | source_no_ndc | 1 | 2026-10-22 | |||
outsourcing:2023-1:1620 | 1620 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-1226 | 73271-1226-1 | Testosterone Cypionate | 2023-1 | valid | 0 | 2026-10-22 | |
outsourcing:2023-2:1620 | 1620 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-8025 | 72682-8025-1 | Testosterone | 2023-2 | valid | 0 | 2026-10-22 | |
outsourcing:2024-1:1620 | 1620 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-056 | 70092-056-05 | Vancomycin Hydrochloride | 2024-1 | valid | 0 | 2026-10-22 | |
outsourcing:2024-2:1620 | 1620 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6074 | 71285-6074-1 | Vancomycin Hydrochloride | 2024-2 | valid | 0 | 2026-10-22 | |
outsourcing:2025-1:1620 | 1620 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Vancomycin Hydrochloride | 2025-1 | source_no_ndc | 1 | 2026-10-22 | |||
compounder:1621 | 1621 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-108 | 70092-108-36 | Fent 2 mcg/ml-Ropiv 0.2% PF 100ml NS IVB | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1621 | 1621 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-22 | |||
outsourcing:2019-2:1621 | 1621 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Rocuronium Bromide | 2019-2 | source_no_ndc | 1 | 2026-10-22 | |||
outsourcing:2020-1:1621 | 1621 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69389-064 | 69389-064-22 | Sarracenia Purpurea | 2020-1 | valid | 0 | 2026-10-22 | |
outsourcing:2020-2:1621 | 1621 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2425 | 72627-2425-1 | Taurine | 2020-2 | valid | 0 | 2026-10-22 | |
outsourcing:2021-1:1621 | 1621 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Pyridoxine Hydrochloride; Thiamine Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-22 | |||
outsourcing:2021-2:1621 | 1621 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-0970 | 5446-0970-03 | Salicylic Acid; Podophyllum Resin; Cantharidin | 2021-2 | valid | 0 | 2026-10-22 | |
outsourcing:2022-1:1621 | 1621 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6078 | 71285-6078-1 | Vancomycin Hydrochloride | 2022-1 | valid | 0 | 2026-10-22 | |
outsourcing:2022-2:1621 | 1621 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Tetracaine; Lidocaine; Benzocaine | 2022-2 | source_no_ndc | 1 | 2026-10-22 | |||
outsourcing:2023-1:1621 | 1621 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-1226 | 73271-1226-2 | Testosterone Cypionate | 2023-1 | valid | 0 | 2026-10-22 | |
outsourcing:2023-2:1621 | 1621 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-8587 | 72682-8587-1 | Testosterone | 2023-2 | valid | 0 | 2026-10-22 | |
outsourcing:2024-1:1621 | 1621 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Vancomycin Hydrochloride | 2024-1 | source_no_ndc | 1 | 2026-10-22 | |||
outsourcing:2024-2:1621 | 1621 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6075 | 71285-6075-1 | Vancomycin Hydrochloride | 2024-2 | valid | 0 | 2026-10-22 | |
outsourcing:2025-1:1621 | 1621 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Vancomycin Hydrochloride | 2025-1 | source_no_ndc | 1 | 2026-10-22 | |||
compounder:1622 | 1622 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 69761-121 | 69761-121-01 | Estradiol / Stearic Acid | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1622 | 1622 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-22 | |||
outsourcing:2019-2:1622 | 1622 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Rocuronium Bromide | 2019-2 | source_no_ndc | 1 | 2026-10-22 | |||
outsourcing:2020-1:1622 | 1622 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69389-064 | 69389-064-27 | Sarracenia Purpurea | 2020-1 | valid | 0 | 2026-10-22 | |
outsourcing:2020-2:1622 | 1622 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-0180 | 73271-0180-1 | Testosterone | 2020-2 | valid | 0 | 2026-10-22 | |
outsourcing:2021-1:1622 | 1622 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ranibizumab | 2021-1 | source_no_ndc | 1 | 2026-10-22 | |||
outsourcing:2021-2:1622 | 1622 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69389-064 | 69389-064-27 | Sarracenia Purpurea | 2021-2 | valid | 0 | 2026-10-22 | |
outsourcing:2022-1:1622 | 1622 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Vancomycin Hydrochloride | 2022-1 | source_no_ndc | 1 | 2026-10-22 |